1. Hu D. Role of anti-inflammatory cytokines IL-35 and IL-37 in asthma. Inflammation 2017;40:697-707.
PUBMED | CROSSREF
2. Choi J, Leung PS, Bowlus C, Gershwin ME. IL-35 and autoimmunity: a comprehensive perspective. Clin
Rev Allergy Immunol 2015;49:327-32.
PUBMED | CROSSREF
3. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev
Immunol 2005;5:521-31.
PUBMED | CROSSREF
4. Olson BM, Sullivan JA, Burlingham WJ. Interleukin 35: a key mediator of suppression and the propagation
of infectious tolerance. Front Immunol 2013;4:315.
PUBMED | CROSSREF
5. Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012;13:722-8.
PUBMED | CROSSREF
6. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U. A functional interleukin
12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A
1996;93:14002-7.
PUBMED | CROSSREF
7. Liu W, Zeng Q, Wen Y, Tang Y, Yan S, Li Y, Zhou L, Luo R. Inhibited interleukin 35 expression and
interleukin 35-induced regulatory T cells promote type II innate lymphoid cell response in allergic
rhinitis. Ann Allergy Asthma Immunol 2020;20:30562-7.
PUBMED | CROSSREF
8. Egwuagu CE, Yu CR, Sun L, Wang R. Interleukin 35: critical regulator of immunity and lymphocytemediated diseases. Cytokine Growth Factor Rev 2015;26:587-93.
PUBMED | CROSSREF
9. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T,
Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD. Interleukin-23 rather than
interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-8.
PUBMED | CROSSREF
10. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ.
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp
Med 2003;198:1951-7.
PUBMED | CROSSREF
https://apallergy.org
https://doi.org/10.5415/apallergy.2021.11.e34
9/10
Anti-inflammatory role of IL-35 in allergic rhinitis
11. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein
RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp
Med 2005;201:233-40.
PUBMED | CROSSREF
12. Yokota M, Suzuki M, Nakamura Y, Ozaki S, Murakami S. Cytokine modulation by IL-35 in mice with
allergic rhinitis. Am J Rhinol Allergy 2015;29:251-6.
PUBMED | CROSSREF
13. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. Airway inflammation and IgE
production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively
attenuated by IL-35. J Immunol 2011;187:462-71.
PUBMED | CROSSREF
14. Dong J, Wong CK, Cai Z, Jiao D, Chu M, Lam CW. Amelioration of allergic airway inflammation in mice
by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy 2015;70:921-32.
PUBMED | CROSSREF
15. Matsubara A, Sakashita M, Goto M, Kawashima K, Matsuoka T, Kondo S, Yamada T, Takeno S, Takeuchi
K, Urahima M, Fujieda S, Okubo K. Epidemiological survey of allergic rhinitis in Japan 2019. Nihon
Jibiinkoka Gakkai Kaiho 2020;123:485-90.
CROSSREF
16. Lao-Araya M, Steveling E, Scadding GW, Durham SR, Shamji MH. Seasonal increases in peripheral innate
lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol
2014;134:1193-5.
PUBMED | CROSSREF
17. Shamji MH, Layhadi JA, Achkova D, Kouser L, Perera-Webb A, Couto-Francisco NC, Parkin RV, Matsuoka
T, Scadding G, Ashton-Rickardt PG, Durham SR. Role of IL-35 in sublingual allergen immunotherapy. J
Allergy Clin Immunol 2019;143:1131-42.
PUBMED | CROSSREF
18. Li Y, Pan X, Peng X, Li S, Zhou Y, Zheng X, Li M. Adenovirus-mediated interleukin-35 gene transfer
suppresses allergic airway inflammation in a murine model of asthma. Inflamm Res 2015;64:767-74.
PUBMED | CROSSREF
19. Suzuki M, Yokota M, Nakamura Y, Ozaki S, Murakami S. Intranasal administration of IL-35 inhibits
allergic responses and symptoms in mice with allergic rhinitis. Allergol Int 2017;66:351-6.
PUBMED | CROSSREF
20. Zhong H, Fan XL, Yu QN, Qin ZL, Chen D, Xu R, Chen DH, Lin ZB, Wen W, Fu QL. Increased innate type 2
immune response in house dust mite-allergic patients with allergic rhinitis. Clin Immunol 2017;183:293-9.
PUBMED | CROSSREF
21. Wang W, Li P, Chen YF, Yang J. A potential immunopathogenic role for reduced IL-35 expression in
allergic asthma. J Asthma 2015;52:763-71.
PUBMED | CROSSREF
22. Wang W, Wei C, Cheng Z, Yang J. Aberrant Th2 immune responses are associated with a reduced
frequency of IL-35-induced regulatory T cells after allergen exposure in patients with allergic asthma.
Allergy Asthma Immunol Res 2020;12:1029-45.
PUBMED | CROSSREF
23. Kabata H, Moro K, Koyasu S. The group 2 innate lymphoid cell (ILC2) regulatory network and its
underlying mechanisms. Immunol Rev 2018;286:37-52.
PUBMED | CROSSREF
24. Doherty TA, Scott D, Walford HH, Khorram N, Lund S, Baum R, Chang J, Rosenthal P, Beppu A, Miller M,
Broide DH. Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate
lymphoid cells that express CD84. J Allergy Clin Immunol 2014;133:1203-5.
PUBMED | CROSSREF
25. Fan D, Wang X, Wang M, Wang Y, Zhang L, Li Y, Fan E, Cao F, Van Crombruggen K, Zhang L. Allergendependent differences in ILC2s frequencies in patients with allergic rhinitis. Allergy Asthma Immunol
Res 2016;8:216-22.
PUBMED | CROSSREF
26. Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu
CE. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014;20:633-41.
PUBMED | CROSSREF
27. Kouzaki H, Arikata M, Koji M, Arai H, Yamamoto S, Kikuoka H, Fujimoto N, Ogawa Y, Yuta A, Shimizu
T. Dynamic change of anti-inflammatory cytokine IL-35 in allergen immune therapy for Japanese cedar
pollinosis. Allergy 2020;75:981-3.
PUBMED | CROSSREF
https://apallergy.org
https://doi.org/10.5415/apallergy.2021.11.e34
10/10
...
論文の公開元へ
